Search

for
Search:

GlossaryEnoxaparin (LMWH)

anticoagulant medication used to prevent and treat blood clots

Enoxaparin, also known by the brand name Lovenox, is a type of anticoagulant medication known as low molecular weight heparin (LMWH). It is used to prevent and treat blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism (PE), by inhibiting certain factors in the blood clotting process.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 31 results

research Venous Thromboembolism and Women's Health

22 citations, October 2018 in “British Journal of Haematology”

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

research Diffuse Alopecia in a Hemodialysis Patient Caused by a Low-Molecular-Weight Heparin, Tinzaparin

15 citations, May 2003 in “American Journal of Kidney Diseases”

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

research Generalized Cutaneous Necrosis: A Complication of Low-Molecular-Weight Heparin

11 citations, September 2005 in “International Wound Journal”

A woman developed severe skin damage after using a blood thinner called low-molecular-weight heparin.

research Eczema-Like, Erythematous, Infiltrated Plaques: A Common Side Effect of Subcutaneous Heparin Therapy

63 citations, October 1989 in “Journal of The American Academy of Dermatology”

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

research Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis

26 citations, August 2006 in “Journal of Clinical Pharmacy and Therapeutics”

Some patients lost hair after being treated with the drug enoxaparin for a brain vein clot.

View more "lmwh" in research →

Community Join

0 / 0 results

— no results